Sanofi-Pasteur H5N1 Avian Flu Vaccine Stimulates Immune Response In Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
The 300-subject study showed that a regimen of two 30 mcg doses with adjuvant was safe and well tolerated.